COST-EFFECTIVENESS OF PROPHYLACTIC USE OF FILGRASTIM IN ADULTS WITH ACUTE LEUKEMIA LYMPHOBLASTIC COLOMBIA

被引：0
|
作者：
Casadiego, E. J.
Rojas, Diaz J. A. [1 ]
Bermudez, C. [2 ]
Prieto-Martinez, V [1 ]
Novoa, Urrego J. R. [3 ]
机构：
[1] Univ Nacl Colombia, Bogota, Colombia
[2] Inst Nacl Cancerol, Mexico City, DF, Mexico
[3] Univ Nacl Colombia, Fac Ciencias, Bogota, Colombia
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.501
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN106
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF FIRST LINE TREATMENT STRATEGIES FOR ACUTE PROMYELOCYTIC LEUKEMIA IN ADULTS IN COLOMBIA
    Molina-Pimienta, L.
    Lara-Puello, I
    Solano-Gil, I. M.
    Rincon, S. L.
    Munoz-Rivas, S.
    Arbelaez-Collazos, L. M.
    McMahon, Del Rio R.
    Arevalo, M.
    Rosselli, D.
    VALUE IN HEALTH, 2023, 26 (06) : S108 - S109
  • [2] ACUTE-LEUKEMIA IN ADULTS - COST-EFFECTIVENESS OF TREATMENT
    VOGEL, LL
    THORUP, OA
    KAISER, DL
    ZIRKLE, JW
    HARLAN, JF
    HESS, CE
    SOUTHERN MEDICAL JOURNAL, 1984, 77 (01) : 51 - 55
  • [3] COST-EFFECTIVENESS ANALYSIS OF BLINATUMOMAB FOR ADVANCED ACUTE LYMPHOBLASTIC LEUKEMIA IN JAPAN
    Ozeki, S.
    Moriwaki, K.
    Morimoto, K.
    Shimozuma, K.
    VALUE IN HEALTH, 2024, 27 (06) : S111 - S111
  • [4] COST-EFFECTIVENESS ANALYSIS OF CLOFARABINE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    Dorantes, M. E. A.
    VALUE IN HEALTH, 2009, 12 (07) : A496 - A496
  • [5] A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia
    Kloos, Robin Q. H.
    van Litsenburg, Raphaele R. L.
    Wolf, Sarah
    Wismans, Leonoor
    Kaspers, Gertjan J. L.
    Uyl-de Groot, Carin A.
    Pieters, Rob
    van der Sluis, Inge M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (01)
  • [6] COST-EFFECTIVENESS ANALYSIS OF PROPHYLACTIC TREATMENT VERSUS A DEMAND IN YOUNG ADULTS WITH SEVERE HEMOPHILIA IN COLOMBIA
    Ordonez Molina, J. E.
    Orozco Giraldo, J. J.
    VALUE IN HEALTH, 2013, 16 (07) : A721 - A721
  • [7] The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia
    Rachael F. Grace
    Daniel J. DeAngelo
    Kristen E. Stevenson
    Donna Neuberg
    Stephen E. Sallan
    Yasser R. Abou Mourad
    Julie Bergeron
    Matthew D. Seftel
    Caroline Kokulis
    Jean M. Connors
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 306 - 314
  • [8] The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia
    Grace, Rachael F.
    DeAngelo, Daniel J.
    Stevenson, Kristen E.
    Neuberg, Donna
    Sallan, Stephen E.
    Abou Mourad, Yasser R.
    Bergeron, Julie
    Seftel, Matthew D.
    Kokulis, Caroline
    Connors, Jean M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (02) : 306 - 314
  • [9] COST-EFFECTIVENESS OF RITUXIMAB IN ADDITION TO STANDARD OF CARE CHEMOTHERAPY FOR ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Nam, J.
    Geirnaert, M.
    Milenkovski, R.
    Paulson, K.
    Yunger, S.
    Seftel, M.
    HAEMATOLOGICA, 2017, 102 : 296 - 296
  • [10] COST-EFFECTIVENESS OF RITUXIMAB IN ADDITION TO STANDARD OF CARE CHEMOTHERAPY FOR ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Nam, J.
    Milenkovski, R. B.
    Yunger, S.
    Geirnaert, M.
    Seftel, M.
    VALUE IN HEALTH, 2017, 20 (05) : A111 - A111
12345